RT Journal Article
SR Electronic
T1 Is <em>Mycobacterium avium</em> subspecies <em>paratuberculosis</em> (MAP) associated with Crohn’s Disease?
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.27.21263960
DO 10.1101/2021.09.27.21263960
A1 Patterson, Joshua M.
A1 Winstead, Cherese
A1 Milligan, Kimberly
YR 2021
UL http://medrxiv.org/content/early/2021/09/27/2021.09.27.21263960.abstract
AB Objective This retroactive meta-analysis assesses the relationship between Mycobacterium avium subspecies paratuberculosis (MAP) and Crohn’s Disease (CD).Methods A meta-analysis of PCR– and culture–based studies was conducted to determine if there is a relationship between MAP and Crohn’s Disease. The chi-squared test of independence was also conducted to determine if MAP infection and Crohn’s disease onset are independent events.Results The studies analyzed were able to provide evidence that Mycobacterium avium subspecies paratuberculosis is highly associated with Crohn’s disease. It is also shown that, regardless of detection method, MAP can effectively be detected in Crohn’s patients.Conclusion MAP is strongly connected with Crohn’s Disease.Summary This paper examines the incidence of MAP in the tissue of Crohn’s disease patients. We found evidence to support MAP being strongly associated with Crohn’s disease.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was recieved or used for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB approval was needed; this work does not use human or animal subjects.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo databases were used; the data can be extracted from the papers analyzed (meta-analysis), listed in the references